Compare · GRAL vs HUM
GRAL vs HUM
Side-by-side comparison of GRAIL Inc. (GRAL) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GRAL and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $42.03B, about 16.3x GRAL ($2.57B).
- Over the past year, GRAL is up 49.1% and HUM is up 49.8% - HUM leads by 0.6 points.
- GRAL has been more active in the news (11 items in the past 4 weeks vs 4 for HUM).
- HUM has more recent analyst coverage (25 ratings vs 12 for GRAL).
- Company
- GRAIL Inc.
- Humana Inc.
- Price
- $59.81-0.26%
- $348.98-0.34%
- Market cap
- $2.57B
- $42.03B
- 1M return
- -5.06%
- +41.10%
- 1Y return
- +49.13%
- +49.75%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 11
- 4
- Recent ratings
- 12
- 25
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest GRAL
- Chief Growth Officer Partridge Andrew John sold $91,070 worth of shares (1,491 units at $61.08), decreasing direct ownership by 0.90% to 163,738 units (SEC Form 4) (withholding obligation)
- Goldman initiated coverage on GRAIL with a new price target
- Chief Executive Officer Ofman Joshua J. was granted 31,055 shares, increasing direct ownership by 8% to 402,271 units (SEC Form 4)
- New insider Partridge Andrew John claimed ownership of 165,229 shares (SEC Form 3)
- Wolfe Research resumed coverage on GRAIL
- GRAIL Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits
- GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
- GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
- GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Latest HUM
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
- Humana upgraded by Deutsche Bank with a new price target
- Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness
- Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
- Chief Financial Officer Mellet Celeste gave a grant of 15,387 units of Humana Common, decreasing direct ownership by 28% to 39,637 units (SEC Form 4)
- Chief Information Officer Mehta Japan was granted 9,448 units of Humana Common, increasing direct ownership by 122% to 17,176 units (SEC Form 4)
- President, Enterprise Growth Dintenfass David was granted 11,273 units of Humana Common, increasing direct ownership by 80% to 25,407 units (SEC Form 4)
- President & CEO Rechtin James A. was granted 35,633 units of Humana Common (SEC Form 4)